Clinical trial
Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's…
NCT00299286 · Institute of Cancer Research, United Kingdom, Other · Completed
Key facts
| NCT number | NCT00299286 |
|---|---|
| Title | Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer |
| Official title | A Double Blind Short-Term Presurgical Study Assessing the Molecular Antiproliferative Predictors of Lapatinib's Effects in Breast Cancer |
| Acronym | MAPLE |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Lapatinib, Lapatinib-Placebo |
| Enrollment | 121 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Mar 6, 2006 |
| Last update posted | Aug 6, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: